跳至主要内容
临床试验/CTRI/2023/08/056750
CTRI/2023/08/056750招募中3 期

Safety and efficacy of low dose albumin compared to recommended dose in patients with cirrhosis and spontaneous bacterial peritonitis - Open labelled randomized controlled trial. - MINS study

AIG Hospitals0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
AIG Hospitals

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient >18 years age and cirrhosis and ascites with PMN count >250/cumm in the absence of secondary bacterial peritonitis. Patient with SBP diagnosed in our hospital.

排除标准

  • Patients less than 18 years of age
  • Hepatocellular carcinoma or peritoneal carcinomatosis
  • Tuberculosis, pancreatitis or bleeding into ascitic fluid (which can elevate the PMN count in ascitic fluid).
  • Cardiac or end-stage kidney disease.
  • Patients with SBP diagnosed in outside hospital
  • Secondary bacterial peritonitis.

研究者

发起方
AIG Hospitals

相似试验

ow dose albumin for patients with cirrhosis and... | 临床试验